The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy

Diabetes is a major cause of visual impairment among working-age adults in the United States. The proliferative form of diabetic retinopathy is associated with severe vision loss (acuity <5/200). The standard treatment in proliferative diabetic retinopathy (PDR) is panretinal photocoagulation (PR...

Full description

Saved in:

Bibliographic Details
Published in:	Drugs in Context Vol. 7; pp. 212532 - 10
Main Authors:	Zhao, Yue, Singh, Rishi P
Format:	Journal Article
Language:	English
Published:	England BioExcel Publishing Ltd 13.08.2018
Subjects:	aflibercept angiogenesis inhibitors antibodies bevacizumab diabetic retinopathy humanized antibodies intravitreal injection monoclonal ranibizumab Review vascular endothelial growth factor A aflibercept bevacizumab antibodies monoclonal intravitreal injection angiogenesis inhibitors diabetic retinopathy vascular endothelial growth factor A humanized antibodies ranibizumab
ISSN:	1745-1981, 1740-4398, 1740-4398
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!